Cavallari, LHBeitelshees, ALBlake, KVDressler, LGDuarte, JDElsey, AEichmeyer, JNEmpey, PEFranciosi, JPHicks, JKHolmes, AMJeng, LJBLee, CRLima, JJLimdi, NAModlin, JObeng, AOPetry, NPratt, VM.Skaar, Todd C.Tuteja, SVoora, DWagner, MWeitzel, KWWilke, RAPeterson, JFJohnson, JA2018-05-312018-05-312017-05Cavallari, L., Beitelshees, A., Blake, K., Dressler, L., Duarte, J., Elsey, A., … Johnson, J. (2017). The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting. Clinical and Translational Science, 10(3), 143–146. https://doi.org/10.1111/cts.124561752-8054https://hdl.handle.net/1805/16320en-USAttribution-NonCommercial-NoDerivs 3.0 United StatesGenotypeUS Food and Drug Administrationdrug responseCPICIGNITEArticle